GlassScriptPhysician profile
Kendra Gillespie
NPI 1588084016
$4,681.49
in general payments reported to CMS, 2019-2025
47 companies · $445 in 2025
The $445 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $848 · 2020: $494 · 2021: $1,576 · 2022: $493 · 2023: $444 · 2024: $380 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,269.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $550.99 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $546.61 | 2019-2025 | |
| Hologic Sales and Service, LLC | $391.83 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Gynesonics, INC. | $324.21 | 2021 | |
| Novo Nordisk INC | $293.30 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $225.78 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $214.75 | 2019-2022 | |
| Daiichi Sankyo INC. | $211.24 | 2019-2023 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $147.84 | 2019-2023 | |
| Medical Device Business Services, INC. | $119.35 | 2021 | |
| Horizon Therapeutics Plc | $111.91 | 2020 | |
| Evofem Biosciences, INC. | $111.05 | 2021-2023 | Phexxi |
| Aspira Women'S Health INC | $100.78 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $95.64 | 2019-2022 | |
| Pfizer INC. | $88.98 | 2019-2024 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $81.58 | 2021-2025 | Paragard T 380a |
| Organon LLC | $80.30 | 2021-2025 | Jada System, Nexplanon |
| Myovant Sciences INC. | $77.53 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $67.53 | 2019-2023 | Belsomra |
| Mayne Pharma Commercial LLC | $65.73 | 2021-2025 | |
| Avion Pharmaceuticals | $61.06 | 2019-2023 | Balcoltra |
| Smith+Nephew, INC. | $53.72 | 2019-2022 | |
| Dexcom, INC. | $51.03 | 2025 | Dexcom G6 Transmitter |
| Coloplast Corp | $48.48 | 2020-2021 | |
| Roche Diagnostics Corporation | $44.05 | 2019-2020 | |
| Agile Therapeutics, INC. | $41.42 | 2022-2023 | Twirla |
| Vivus LLC | $40.57 | 2021 | |
| Sage Therapeutics, LLC | $37.04 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $36.15 | 2021 | |
| Exact Sciences Corporation | $31.14 | 2023-2024 | Cologuard Collection Kit |
| Innovation Technologies INC | $29.75 | 2025 | Irrisept |
| Virtus Pharmaceuticals LLC | $28.75 | 2021 | |
| Exeltis, USA INC. | $25.91 | 2021 | |
| Bioventus LLC | $24.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $23.52 | 2023 | Exparel |
| Lsi Solutions INC | $20.66 | 2024 | Fornisee |
| Optumhealth Care Solutions, LLC | $20.10 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Davol INC. | $18.78 | 2021 | |
| Stryker Corporation | $18.02 | 2021 | |
| Becton, Dickinson and Company | $17.25 | 2021 | |
| Mission Pharmacal Company | $17.11 | 2019 | |
| Shield Therapeutics INC | $16.86 | 2022 | |
| Millicent US INC | $16.78 | 2020 | |
| Baxter Healthcare | $15.84 | 2025 | Perclot |
| Alexion Pharmaceuticals, INC. | $14.00 | 2019 | |
| Minerva Surgical, INC | $12.47 | 2021 | |
| Aroa Biosurgery Incorporated | $10.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Gillespie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.